newsfilter
← Interviews
Sourcery with Molly O'Shea1h 0m

Race to Save Humanity: Inside $12B Colossal Biosciences & $3.8B Astromech

Ben Lamm, George Church, Molly O'Shea

Interview

Colossal is leveraging a de-extinction toolkit and AI-driven "civilization tech" to address an impending 50% global biodiversity loss while raising $400 million in recent capital. Following a breakthrough in generating healthy woolly mice for rapid phenotype testing, the company aims to birth its first extinct species within 12 months by utilizing an 80% efficient cloning arm and open-source technologies. This vertical integration strategy targets ethical textile production and invasive species eradication, operating under strict ethical boundaries that exclude human or primate genome editing.